|
|
|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
«
Ham
John »
|
 |
|
|
Hamilton BioVentures
Offices: San Diego, California
Hamilton BioVentures is a venture capital
firm (with $100 million under management)
investing in talented entrepreneurs bringing
new Life Science technology enterprises
to market. Hamilton BioVentures invests
in companies developing dramatically better
treatments (biopharmaceuticals and medical
devices) for major human diseases and other
medical conditions. Their investments
generally take the form of direct equity
in early-stage companies located on the
West Coast. |
Hatteras Venture Partners
Offices: Durham, North Carolina
Hatteras Venture Partners is a venture capital
firm with a focus on biopharmaceuticals,
medical devices, diagnostics, and related
opportunities in human medicine. Founded
in 2000, the firm consists of an experienced
team with a broad and complementary skill
set that is particularly relevant to building
successful new biomedical companies. The
Hatteras Venture Partners team brings operational
experience, a successful track record, and
a proven ability to enhance the value of
the companies in which it invests. |
HBM Partners
Offices: Zurich, Switzerland
HBM Partners is a provider of investment
advisory services specialized in the global
life sciences sector. It focuses on investments
in biotechnology, emerging pharma, medical
technology, and related industry segments.
HBM Partners is one of the world’s largest
investment advisory groups in this field.
Its spectrum of investments covers private
and public companies as well as specialized
venture capital funds. HBM Partners can
rely on the extensive scientific, operational,
and financial experience of some 15 experts. |
HealthCare Ventures (HCV)
Offices: Princeton, New Jersey & Cambridge,
England
HealthCare Ventures is one of the world's
largest venture capital firms specializing
in health care, making investments in early
stage and emerging growth companies that
have the potential for exceptional growth.
The firm has successfully raised and managed
seven funds in the past nineteen years.
HCV is dedicated to creating companies that
will develop and market products and services
that meet important medical needs. |
Health Evolution Partners
Offices: San Francisco, California
Health Evolution Partners invests in the
world’s leading health care companies. They
seek out companies that are driving critical
shifts in the ways health care is financed,
organized and delivered. Their investments
will accelerate health care’s transformation
into a high quality, efficient and consumer-driven
industry. Health Evolution Partners is guided
by a team of exceptional health care leaders,
experienced private equity investors, seasoned
policymakers and operating experts. |
|
|
IngleWood Ventures
Offices: San Diego, California
IngleWood's charter is to invest in a diversified
portfolio of early-stage biotechnology and
medical technology companies. Their areas
of focus include drug discovery/tools, medical
devices and diagnostics and healthcare information
technology. Their preferred investment size
is $500,000 to $1.5 million initially and
up to $2.66 million per company over time.
|
Integra Ventures
Offices: Seattle, Washington
Integra Ventures seek investments in Life
Science companies in three principal areas:
Drug Discovery, Medical Devices, and Healthcare
Services. They consider business plans from
experienced entrepreneurs passionately pursuing
disruptive opportunities that fulfill large
unmet medical or market needs. Integra's
strategy is to develop a portfolio of outstanding
regional and national biomedical companies
chosen within the framework of their partner's
extensive biomedical, service and device
expertise. |
Ivy Capital Partners
Offices: Montvale, New Jersey
Ivy Capital Partners is a specialized private
equity investment firm dedicated to investing
in promising companies operating in the
musculoskeletal sector of the healthcare
industry. Their focus on musculoskeletal
companies stems from their belief that a
number of compelling macroeconomic, demographic
and scientific trends bode well for the
future of this large and rapidly growing
sector. |
| |
|
|
|
|
|
Bio Life (Johnson)
Resources
to
top